Results 111 to 120 of about 14,652 (127)

Empagliflozin

Reactions Weekly, 2018
  +4 more sources

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Circulation, 2022
Javed Butler, Gerasimos S Filippatos, Martina Brueckmann   +2 more
exaly  

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

New England Journal of Medicine, 2020
Milton Packer, Stefan D Anker, Javed Butler   +2 more
exaly  

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure

Circulation, 2023
Milton Packer, Javed Butler, Cordula Zeller   +2 more
exaly  

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors, Christiane Angermann Angermann, John R Teerlink   +2 more
exaly  

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status

Circulation, 2021
Stefan D Anker, Javed Butler, Gerasimos S Filippatos   +2 more
exaly  

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

Circulation, 2021
Matthew Lee, Kenneth Mangion, Giles Roditi, Frcp, Frcr   +2 more
exaly  

Empagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2023
exaly  

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

Circulation, 2022
Javed Butler, Gerasimos S Filippatos, João Pedro Ferreira   +2 more
exaly  

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

Circulation, 2021
Milton Packer, Javed Butler, Faiez Zannad   +2 more
exaly